<DOC>
	<DOCNO>NCT01662635</DOCNO>
	<brief_summary>Because ALK-positive lung cancer constitute less 5 % lung cancer , critically important select patient likely ALK mutation . Clinical characteristic patient mutation target gene also know , incidence give target mutation establish specific population . There incidence know Mexican population , believe great .</brief_summary>
	<brief_title>Clinicopathological Features NSCLC Patients Associated With Chromosome 2p ( EML4-ALK )</brief_title>
	<detailed_description>Lung adenocarcinoma study . The inclusion criterion availability tissue biomarker study . To identify ALK rearrangement , fluorescence situ hybridization ( FISH ) study perform 3 4 mm thick paraffin section NSCLCs . The commercially label Vysis LSI ALK Dual Color ( split-apart ) , break-apart rearrangement probe ( Abbott Molecular , Abbott Park , IL ) use detect rearrangement involve ALK gene . The probe hybridize band 2p23 , either side ALK gene breakpoint . Criteria probe signal interpretation least 200 interphase nuclei follow : 1 ) separate green orange signal single red signal identify cell rearrange ALK ; 2 ) overlap red green signal ( yellowish ) indicate cell ALK rearrange . FISH-positive sample ALK rearrangement define cell clearly separate pair probe signal , &gt; 15 % cell loss 5Â´ ( centromeric ) probe . The high threshold loss necessary part probe lose sectioning . The aim study evaluate utility IHC 5A4 RT-qPCR detection ALK rearrangements NSCLC compare current method choice , FISH . Further , report demographic , clinicopathologic feature ALK-rearranged NSCLC Latin-American population . Clinical detail patient include database . Further result analyzed program SPSS17</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>The inclusion criterion availability tissue biomarker study . Disease Progression</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Non-small cell lung cancer .</keyword>
	<keyword>Diagnosis ,</keyword>
	<keyword>Adenocarcinoma ,</keyword>
	<keyword>ALK ,</keyword>
	<keyword>FISH ,</keyword>
	<keyword>IHC</keyword>
	<keyword>RT-qPCR</keyword>
</DOC>